| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/22/1999 | WO1999006578A3 Genetic method for controlling sprouting |
| 04/22/1999 | WO1999006577A3 Agent for expressing and detecting a fusion polypeptide with an hpol-epitope and a polypeptide |
| 04/22/1999 | WO1999006570A3 Plasmids |
| 04/22/1999 | WO1999006561A3 Chemokine receptor ccr8 dna and uses thereof |
| 04/22/1999 | WO1999006552A3 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN BRAIN |
| 04/22/1999 | WO1999005315A3 Nucleic acid sequence analysis |
| 04/22/1999 | WO1999005264A3 Production of human mutant proteins in human cells by homologous recombination |
| 04/22/1999 | WO1999004267A3 Test device and method for detecting an analyte in a sample |
| 04/22/1999 | WO1999004024A3 Nucleotide sequences of genes encoding sink proteins and uses thereof for improving the nutritional quality of feeds |
| 04/22/1999 | WO1999004011A3 Hiv-1 group o antigens and uses thereof |
| 04/22/1999 | WO1999004007A8 Increasing production of proteins in gram-positive microorganisms |
| 04/22/1999 | WO1999003981A8 Nucleic acid expression constructs incorporating a heterologous intron whose natural position is within the 5'untranslated region of its gene |
| 04/22/1999 | WO1999002693A3 Microbial swollenin protein; dna sequences encoding such swollenins and method of producing such swollenins |
| 04/22/1999 | WO1999001565A9 Method for increasing secretion of proteins in eukaryotic host cells |
| 04/22/1999 | WO1999001556A3 IMPROVED ANTI-IgE ANTIBODIES AND METHOD OF IMPROVING POLYPEPTIDES |
| 04/22/1999 | WO1998059055A3 Detoxifying proteins |
| 04/22/1999 | WO1998058957A3 Disulfide cross-linked glycoprotein hormone analogs, their preparation and use |
| 04/22/1999 | WO1998058745A9 Electrospraying solutions of substances for mass fabrication of chips and libraries |
| 04/22/1999 | WO1998053068A9 Smad7 and uses thereof |
| 04/22/1999 | WO1998048837A9 Polyalkylene oxide-modified single chain polypeptides |
| 04/22/1999 | WO1998047921A9 Mammalian cytokines; related reagents and methods |
| 04/22/1999 | WO1998045328A3 Compositions and methods for the treatment and diagnosis of breast cancer |
| 04/22/1999 | WO1998044143A9 Polymer-modified viruses |
| 04/22/1999 | WO1998036779A3 System for the in vivo delivery and expression of heterologous genes in the bone marrow |
| 04/22/1999 | WO1998008934A9 Serum-free mammalian cell culture medium, and uses thereof |
| 04/22/1999 | WO1997038729A8 In vivo gene transfer methods for wound healing |
| 04/22/1999 | CA2792406A1 Methods for encapsulating nucleic acids in lipid bilayers |
| 04/22/1999 | CA2745783A1 .alpha.-amylase mutants |
| 04/22/1999 | CA2696653A1 Mammalian genes involved in viral infection and tumor suppression |
| 04/22/1999 | CA2315819A1 Screening for novel compounds which regulate biological interactions |
| 04/22/1999 | CA2315244A1 Transgenic animal models for cardiac hypertrophy and uses thereof |
| 04/22/1999 | CA2308121A1 Mammals lacking expression of osteoprotegerin |
| 04/22/1999 | CA2308118A1 Immuno-reactive peptide ctl epitopes of human cytomegalovirus |
| 04/22/1999 | CA2308009A1 Novel npy family member |
| 04/22/1999 | CA2307840A1 Protein production in transgenic avians |
| 04/22/1999 | CA2307328A1 Cell division regulators |
| 04/22/1999 | CA2306455A1 Human receptor proteins; related reagents and methods |
| 04/22/1999 | CA2306453A1 Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof |
| 04/22/1999 | CA2306451A1 Methods and compositions for detecting hepatitis e virus |
| 04/22/1999 | CA2306448A1 Models and treatments for cardiac hypertrophy in relation with nf-at3 function |
| 04/22/1999 | CA2306444A1 Inhibition of human immunodeficiency virus (hiv-1) replication |
| 04/22/1999 | CA2306443A1 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities |
| 04/22/1999 | CA2306440A1 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle |
| 04/22/1999 | CA2306344A1 Method of building and maintaining bone |
| 04/22/1999 | CA2306228A1 Therapeutic methods comprising use of a neuregulin |
| 04/22/1999 | CA2306207A1 Geranyl diphosphate synthase from mint (mentha piperita) |
| 04/22/1999 | CA2306062A1 Methods and compositions for the treatment of autoimmune disease using heat shock proteins |
| 04/22/1999 | CA2305817A1 Methods for obtaining plant varieties |
| 04/22/1999 | CA2305713A1 Apo-3 ligand |
| 04/22/1999 | CA2305698A1 Human progesterone receptor complex p23-like protein |
| 04/22/1999 | CA2305690A1 53 human secreted proteins |
| 04/22/1999 | CA2305675A1 .beta.-adrenergic receptor polymorphisms |
| 04/22/1999 | CA2305643A1 Murine model for human carcinoma |
| 04/22/1999 | CA2305449A1 Replica amplification of nucleic acid arrays |
| 04/22/1999 | CA2304169A1 Laminins and uses thereof |
| 04/22/1999 | CA2303844A1 Regulators of ucp3 gene expression |
| 04/22/1999 | CA2302810A1 Method and kit for amplification, sequencing and typing of classical hla class i genes |
| 04/22/1999 | CA2275135A1 Phosphodiesterase 8a |
| 04/22/1999 | CA2248762A1 Antisense oligodeoxynucleotides regulating expression of tnf-.alpha. |
| 04/21/1999 | EP0909823A2 Detection of nucleic acids by fluorescence quenching |
| 04/21/1999 | EP0909821A2 Engineering enzymes having altered substrate specificity |
| 04/21/1999 | EP0909820A2 Histidine kinase from Staphylococcus pneumoniae |
| 04/21/1999 | EP0909817A1 Uses of gro genes and proteins |
| 04/21/1999 | EP0909816A1 Anti-fas antibodies |
| 04/21/1999 | EP0909815A2 Dna sequence conferring cytoplasmic male sterility, mitochondrial genome, nuclear genome, mitochondria and plant containing said sequence and process for the preparation of hybrids |
| 04/21/1999 | EP0909814A2 Use of protein kinases for the diagnosis and treatment of Alzheimer's disease |
| 04/21/1999 | EP0909813A1 Totipotent hematopoietic stem cell receptors -flk-1 and flk-2, and their ligands |
| 04/21/1999 | EP0909331A1 System for detecting protein-protein interactions |
| 04/21/1999 | EP0909330A1 Diagnostic method and apparatus |
| 04/21/1999 | EP0909327A2 Erythromycins and process for their preparation |
| 04/21/1999 | EP0909326A1 Acyltransferase and gene encoding acyltransferase |
| 04/21/1999 | EP0909325A2 Pi 3-kinase fusion mutants and uses thereof |
| 04/21/1999 | EP0909324A2 Toxins active against pests |
| 04/21/1999 | EP0909323A1 Helicobacter pylori bacterioferritin |
| 04/21/1999 | EP0909322A1 Antiviral ricin-like proteins |
| 04/21/1999 | EP0909321A2 Mammalian chemokine reagents |
| 04/21/1999 | EP0909320A1 CHEMOKINE beta-15 |
| 04/21/1999 | EP0909319A2 Growth arrest gene compositions and methods |
| 04/21/1999 | EP0909318A1 Human stem cell antigens, dna coding therefor and their use |
| 04/21/1999 | EP0909317A1 Composition and methods for modulating the length of telomeres |
| 04/21/1999 | EP0909316A1 Glial cell line-derived neurotrophic factor receptor |
| 04/21/1999 | EP0909315A2 Cck-2, a receptor tyrosine kinase |
| 04/21/1999 | EP0909314A1 Plant sugar sensors and uses thereof |
| 04/21/1999 | EP0909313A1 Methods for creating transgenic animals |
| 04/21/1999 | EP0909312A1 Method for the production of polypeptides |
| 04/21/1999 | EP0909278A1 Nephropathy-related immunoglobulin g and antibodies for same |
| 04/21/1999 | EP0909277A2 Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods |
| 04/21/1999 | EP0909273A1 A transcription factor |
| 04/21/1999 | EP0909272A1 Helicobacter pylori adhesin binding group antigen |
| 04/21/1999 | EP0909181A1 Novel compounds |
| 04/21/1999 | EP0909180A1 Novel compounds |
| 04/21/1999 | EP0759991B1 Genes involved in the biosynthetic pathway of carbapenem |
| 04/21/1999 | EP0688366A4 Sensitive nucleic acid sandwich hybridization assays and kits |
| 04/21/1999 | EP0674660B1 Multifunctional neurotrophic factors |
| 04/21/1999 | EP0672188A4 Method for selecting nucleic acids on the basis of structure. |
| 04/21/1999 | EP0664834B1 Recombinant humanized anti-cytomegalovirus antibodies |
| 04/21/1999 | EP0644947B1 Anti-idiotypic monoclonal antibodies against the lewis y-specific monoclonal antibody br55-2 and their uses |
| 04/21/1999 | EP0640131B1 Genetically engineered antibodies |
| 04/21/1999 | EP0609280B1 Human il-3 variants |
| 04/21/1999 | EP0543889B1 Incorporation of selectably clevable sites into oligonucleotide chains and reagents therefor |